4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Inebilizumab for the Treatment of Patients With Type 1 Autoimmune PancreatitisChronic Disease, Digestive System Diseases, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Type 1 Autoimmune Pancreatitis, autoimmune disease, autoimmune pancreatitis, chronic pancreatitis, immune system disorder, pancreas disorder, pancreatitisRecruitingPhase 42026-10-07NCT07862075
A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of RecurrenceChronic Disease, Digestive System Diseases, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Type 1 Autoimmune Pancreatitis, autoimmune disease, autoimmune pancreatitis, chronic pancreatitis, immune system disorder, pancreas disorder, pancreatitisRecruitingPhase 42026-10-06NCT06468709
Validation of the Odesa Criteria 2026 for Autoimmune PancreatitisChronic Disease, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Immunoglobulin G4-Related Disease, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune pancreatitis, chronic pancreatitis, endocrine system disorder, immune system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, pancreatitisRecruitingNot stated2026-05-28NCT07536841
Validation of Joint-AI in Diagnosing Pancreatic Solid LesionsChronic Disease, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune pancreatitis, chronic pancreatitis, endocrine system disorder, immune system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, pancreatitis, solid pseudopapillary neoplasm of the pancreasNot yet recruitingNot applicable2024-12-31NCT06753318